Delving into the Latest Updates on Beijing Xingda Science System Company with Synapse

Overview

Tags

Respiratory Diseases

Neoplasms

Urogenital Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

DNA	1

Primary objective: To preliminarily explore the efficacy and safety of dicycloplatin injection in patients with mCRPC. Secondary objective: To evaluate the pharmacokinetic characteristics of dicycloplatin injection after multiple doses in patients with mCRPC and conduct an exploratory study on possible active metabolites.

Start Date-

Sponsor / Collaborator

Beijing Sopuxingda Pharmaceutical Research Co., Ltd.

[+1]

100 Clinical Results associated with Beijing Xingda Science System Company

Login to view more data

0 Patents (Medical) associated with Beijing Xingda Science System Company

Login to view more data

100 Deals associated with Beijing Xingda Science System Company

Login to view more data

100 Translational Medicine associated with Beijing Xingda Science System Company

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data